Calendar Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-06-04 am EDT			5-day change	1st Jan Change
283.85 ^DKK	+4.43%		-3.11%	-12.73%

02:31pm	Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits	RE
11:50am	Novo Nordisk Reports Real-World Evidence Comparing Semaglutide 2 Mg Dose Escalation Versus Switch to Tirzepatide in Adults with Type 2 Diabetes	CI

Chart calendar Novo Nordisk A/S

7f8ea9bb59da695aa9295f.9a5vHtu0X-2-Ya69y5ZZdD9tmBsxHoEHmAHJlehzsZA.s_scZJLkCavZCOXnm-NqDV0B6kReaddN8Uic_aMm4qa2lwR6utsevusF9w~c32d24ab0c1a6bc5cca8bd469ed09a43

Upcoming events on Novo Nordisk A/S

2026-06-07	Information meeting	07:30 pm
2026-08-05	Earnings release - Q2 2026
2026-09-19	Analyst/Investor Day
2026-09-20	Analyst/Investor Day
2026-11-03	Earnings release - Q3 2026
2027-02-02	Earnings release - Annual 2026

Past events on Novo Nordisk A/S

2026-05-06	Earnings release - Q1 2026
2026-05-06	Earnings presentation	07:00 am
2026-03-26	Présentation aux Actionnaires / Analystes	09:00 am
2026-03-26	Annual General Meeting	09:00 am
2026-03-26	Présentation aux Actionnaires / Analystes	12:00 pm
2026-02-23	Information meeting	05:30 am
2026-02-05	Earnings presentation	08:15 am
2026-02-04	Earnings release - Q4 2025
2026-02-04	Earnings presentation	07:00 am
2025-11-14	Extraordinary General Meeting	08:00 am
2025-11-14	Présentation aux Actionnaires / Analystes	08:00 am
2025-11-05	Earnings release - Q3 2025	01:30 am
2025-11-05	Earnings presentation	06:30 am
2025-10-21	Information meeting	09:00 am
2025-09-17	Information meeting	12:30 pm
2025-08-07	Earnings presentation	08:15 am
2025-08-06	Earnings release - Q2 2025	01:30 am
2025-08-06	Earnings presentation	07:00 am
2025-07-29	Information meeting	10:00 am
2025-07-29	Information meeting	08:30 am

Past dividends on Novo Nordisk A/S

2026-03-27	Ex-dividend date - 7.95 DKK	12:00 am
2025-08-15	Ex-dividend date - 3.75 DKK	12:00 am

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million DKK	Released Forecast Spread	232 261 228 920 1.46%	290 403 285 429 1.74%	309 064 307 426 0.53%	292 419	299 099	319 425
EBITDA Million DKK	Released Forecast Spread	111 987 109 530 2.24%	147 446 141 939 3.88%	149 640 149 253 0.26%	143 002	141 566	152 180
EBIT Million DKK	Released Forecast Spread	102 574 101 255 1.3%	128 339 126 210 1.69%	127 658 128 737 -0.84%	121 735	119 883	129 240
Earnings before Tax (EBT) Million DKK	Released Forecast Spread	104 674 102 184 2.44%	127 191 125 432 1.4%	130 540 130 622 -0.06%	127 204	119 572	128 323
Net income Million DKK	Released Forecast Spread	83 683 82 021 2.03%	100 988 100 215 0.77%	102 434 102 607 -0.17%	98 693	93 986	101 497
EPS DKK	Released Forecast Spread	18,6 18,3 1.79%	22,6 22,3 1.67%	23,0 23,0 0.13%	22,6	21,2	23,2
Announcement Date		31/01/24	05/02/25	03/02/26	-

Quarterly results

Fiscal Period	March	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million DKK	Released Forecast Spread	71 311 71 869 -0.78%	85 683 80 179 6.86%	78 087 78 019 0.09%	76 857 77 114 -0.33%	74 976 77 075 -2.72%	79 144 76 674 3.22%	70 063 71 556 -2.09%	72 066	71 496	73 964	76 325	77 875	77 140	81 540
EBITDA Million DKK	Released Forecast Spread	35 972 36 184 -0.59%	41 935 36 501 14.89%	42 621 40 715 4.68%	38 282 38 965 -1.75%	31 439 34 245 -8.19%	37 298 39 048 -4.48%	36 394 33 818 7.62%	34 816	34 439	32 584
EBIT Million DKK	Released Forecast Spread	33 822 33 301 1.57%	36 737 32 939 11.53%	38 791 36 740 5.58%	33 449 34 694 -3.59%	23 682 24 684 -4.06%	31 736 31 267 1.5%	32 858 34 029 -3.44%	28 735	28 117	26 249
Earnings before Tax (EBT) Million DKK	Released Forecast Spread	34 384 33 325 3.18%	35 557 31 943 11.31%	37 033 35 000 5.81%	33 805 34 568 -2.21%	25 517 26 943 -5.29%	34 185 33 366 2.45%	62 172 37 106 67.55%	28 584	26 964	23 876
Net income Million DKK	Released Forecast Spread	27 301 26 877 1.58%	28 230 25 743 9.66%	29 034 27 298 6.36%	26 503 27 136 -2.33%	20 006 21 390 -6.47%	26 891 25 969 3.55%	48 557 29 435 64.97%	22 189	21 429	19 169	26 345	25 263	24 396	22 577
EPS DKK	Released Forecast Spread	6,12 5,98 2.32%	6,34 5,76 10.06%	6,53 6,15 6.1%	5,96 6,07 -1.87%	4,50 4,59 -1.91%	6,04 5,89 2.63%	10,9 6,70 62.73%	5,01	4,85	4,23	5,97	5,73	5,53	5,12
Announcement Date		06/11/24	05/02/25	07/05/25	06/08/25	05/11/25	03/02/26	06/05/26	-	-	-	-	-	-	-

Upcoming sector events for Novo Nordisk A/S

2026-06-07	CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.	Annual General Meeting	09:00 pm
2026-06-08	ROCHE HOLDING AG	Présentation aux Actionnaires / Analystes	11:00 am
2026-06-08	ORGANON & CO.	Annual General Meeting
2026-06-08	BORA PHARMACEUTICALS CO., LTD.	Annual General Meeting	09:00 pm
2026-06-08	ALIVUS LIFE SCIENCES LIMITED	Présentation aux Actionnaires / Analystes
2026-06-08	NANJING VAZYME BIOTECH CO., LTD	Extraordinary General Meeting	02:30 am
2026-06-08	PACIRA BIOSCIENCES, INC.	Annual General Meeting
2026-06-09	DR. REDDY'S LABORATORIES LIMITED	Présentation aux Actionnaires / Analystes	12:30 am
2026-06-09	ANTHEM BIOSCIENCES LIMITED	Présentation aux Actionnaires / Analystes
2026-06-09	ORGANON & CO.	Présentation aux Actionnaires / Analystes	09:00 am

More events

Past sector events for Novo Nordisk A/S

2026-06-05	LIGAND PHARMACEUTICALS INCORPORATED	Annual General Meeting	11:30 am
2026-06-05	CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO.,LTD	Annual General Meeting	02:00 am
2026-06-05	LUSHANG FREDA PHARMACEUTICAL CO.,LTD.	Earnings presentation	03:00 am
2026-06-05	PT TEMPO SCAN PACIFIC TBK	Présentation aux Actionnaires / Analystes	04:00 am
2026-06-04	ROYALTY PHARMA PLC	Annual General Meeting	09:00 am
2026-06-04	DR. REDDY'S LABORATORIES LIMITED	Présentation aux Actionnaires / Analystes	10:30 pm
2026-06-04	HUMANWELL HEALTHCARE (GROUP) CO.,LTD.	Annual General Meeting	09:30 pm
2026-06-04	GRAND PHARMACEUTICAL GROUP LIMITED	Annual General Meeting	11:00 pm
2026-06-04	PT KALBE FARMA TBK.	Ex-dividend date - 20 IDR	12:00 am
2026-06-04	GUANGXI WUZHOU ZHONGHENG GROUP CO., LTD	Extraordinary General Meeting	10:00 pm